Evidence map›Paper›PMID 36644230›Full record

ArticleJournal of oncology2023

Histone Deacetylase 1 Expression and Regulatory Network in Lung Adenocarcinoma Based on Data Mining and Implications for Targeted Treatment.

Yueyuan Zhong, Mingdong Li, Shihui Guo, Minhua Li, Zitong Cao, Xueyao Luo, Jianhong Liu, Runzhang Liang, Yingqi Shao, Yue Yang and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Yueyuan ZhongThe Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, China.
Mingdong LiDepartment of Gastroenterology, Zibo Center Hospital, Zibo, China.
Shihui GuoThe Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, China.
Minhua LiThe Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, China.
Zitong CaoThe Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, China.
Xueyao LuoThe Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, China.
Jianhong LiuThe Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, China.
Runzhang LiangThe Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, China.
Yingqi ShaoThe Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, China.
Yue YangThe Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, China.
Xinqia ChenThe Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, China.
Chuzhong WeiThe Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, China.
Weijun LingThe Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, China.
Xiao ZhuThe Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, China.ORCID https://orcid.org/0000-0002-1737-3386
Yongmei HuangThe Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, China.ORCID https://orcid.org/0000-0003-2926-4635
Guangdong Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Histone deacetylase 1 (HDAC1) codes a protein that is a component of the histone deacetylase complex. The abnormal expression of HDAC1 is strongly correlated with cell proliferation, differentiation, transcription, and translation. Through continuous screening of genes associated with changes in lung adenocarcinoma (LUAD), gene networks are formed to explore tumor pathogenesis and new therapeutic targets. Methods: We evaluated HDAC1 gene survival analysis and its expression of LUAD using relevant websites and databases (TCGA and GEO databases). Through data mining, we determined the frequency and type of HDAC1 mutation, obtained the relevant heat map of the gene interaction network, completed the analysis of gene ontology and function enrichment, and understood the pharmaceutic of HDAC1. Results: We found that HDAC1 expression was associated with the prognosis of patients with LUAD. In gene expression analysis, HDAC1 was highly expressed in LUAD, and the HDAC1 interaction gene network (MARCKSL, eIF3I) was closely related to cellular gene expression. Functional network analysis shows that the expression of HDAC1 is related to the monitoring point of the G1-S phase of the cell cycle and the activation of the Notch signaling pathway (CSL transcription factor), which is involved in the process of cell proliferation and differentiation and gene expression associated with new therapeutic targets. Conclusion: Our data revealed the expression and potential regulatory factors of HDAC1 in LUAD of data mining, which laid a foundation for the study of the occurrence, development, and treatment of HDAC1 in LUAD.

Identifiers

PMID36644230
PMCPMC9833904
OpenAlexW4313590571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.